Mainz Biomed expands into Romania through partnership with Bioclinica

Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, is excited to announce the addition of Bioclinica to its esteemed network of laboratory partners. Bioclinica will play a crucial role in supporting the commercialization efforts of ColoAlert, Mainz Biomed’s flagship product—a highly effective and user-friendly at-home detection test for colorectal cancer (CRC). This strategic collaboration marks another milestone in Mainz Biomed’s mission to revolutionize the diagnosis and prevention of life-threatening diseases, particularly CRC, which continues to be the second most lethal cancer in Europe.

“We are delighted to welcome Bioclinica as a ColoAlert partner,” stated Darin Leigh, Chief Commercial Officer of Mainz Biomed. “In executing our commercial strategy, we remain steadfast in aligning ourselves with laboratories that share our unwavering dedication to introducing cutting-edge diagnostic tests capable of making a profound impact on the treatment and prevention of critical diseases like CRC. Early detection is paramount in enhancing patient survival rates, and our partnership with Bioclinica in Romania exemplifies our commitment to this cause.”

ColoAlert’s unique business model sets it apart from traditional methodologies in the industry. Rather than operating a single facility, Mainz Biomed has chosen to collaborate with third-party laboratories for the processing of ColoAlert test kits. This approach allows Mainz Biomed to leverage the expertise and resources of established organizations like Bioclinica, ensuring widespread availability and accessibility of the test across Europe and select international markets. According to United Nations, Department of Economic and Social Affairs population statistics, ColoAlert screening has the potential to benefit over 6 million individuals aged between 50 and 74 years in Romania where the CRC incidence rates are among the highest in Europe.

Mainz Biomed is providing ColoAlert to Bioclinica under the standard terms of the Company’s partnership agreements. Bioclinica is a leading supplier of healthcare products in Romania, with over 25 years of experience in medical diagnostics. Through its 15 associated laboratories and 146 collection points, Bioclinica provides state-of-the-art diagnostics to the Romanian population. In the coming weeks, Mainz Biomed will work with Bioclinica to prepare and launch co-marketing activities to ensure a successful commercial launch in these markets.
MB Bureau